<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31883139</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>92</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>A European multicentre evaluation of detection and typing methods for human enteroviruses and parechoviruses using RNA transcripts.</ArticleTitle><Pagination><StartPage>1065</StartPage><EndPage>1074</EndPage><MedlinePgn>1065-1074</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.25659</ELocationID><Abstract><AbstractText>Polymerase chain reaction (PCR) detection has become the gold standard for diagnosis and typing of enterovirus (EV) and human parechovirus (HPeV) infections. Its effectiveness depends critically on using the appropriate sample types and high assay sensitivity&#xa0;as viral loads in cerebrospinal fluid samples from meningitis and sepsis clinical presentation can be extremely low. This study evaluated the sensitivity and specificity of currently used commercial and in-house diagnostic and typing assays. Accurately quantified RNA transcript controls were distributed to 27 diagnostic and 12 reference laboratories in 17 European countries for blinded testing. Transcripts represented the four human EV species (EV-A71, echovirus 30, coxsackie A virus 21, and EV-D68), HPeV3, and specificity controls. Reported results from 48 in-house and 15 commercial assays showed 98% detection frequencies of high copy (1000 RNA copies/5&#x2009;&#xb5;L) transcripts. In-house assays showed significantly greater detection frequencies of the low copy (10 copies/5&#x2009;&#xb5;L) EV and HPeV transcripts (81% and 86%, respectively) compared with commercial assays (56%, 50%; P&#x2009;=&#x2009;7&#x2009;&#xd7;&#x2009;10<sup>-5</sup> ). EV-specific PCRs showed low cross-reactivity with human rhinovirus C (3 of 42 tests) and infrequent positivity in the negative control (2 of 63 tests). Most or all high copy EV and HPeV controls were successfully typed (88%, 100%) by reference laboratories, but showed reduced effectiveness for low copy controls (41%, 67%). Stabilized RNA transcripts provide an effective, logistically simple and inexpensive reagent for evaluation of diagnostic assay performance. The study provides reassurance of the performance of the many in-house assay formats used across Europe. However, it identified often substantially reduced sensitivities of commercial assays often used as point-of-care tests.</AbstractText><CopyrightInformation>&#xa9; 2019 The Authors. Journal of Medical Virology published by Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Microbiology Laboratory, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ant&#xf3;n</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Respiratory Viruses Unit, Virology Section, Microbiology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute, Universitat Aut&#xf2;noma de Barcelona, Passeig Vall d'Hebron, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bailly</LastName><ForeName>J-L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Clermont Auvergne, LMGE UMR CNRS, UFR M&#xe9;decine, Clermont-Ferrand, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CHU Clermont-Ferrand, National Reference Center for EV and Parechovirus-Associated Laboratory, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beard</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Enteric Virus Unit, Virus Reference Department, National Infection Service, Public Health England, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benschop</LastName><ForeName>K S M</ForeName><Initials>KSM</Initials><AffiliationInfo><Affiliation>National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berginc</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department for Public Health Virology, National Laboratory of Health, Environment and Food, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blomqvist</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Institute for Health and Welfare, Mannerheimintie, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cunningham</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Viapath Infection Sciences, St. Thomas' Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Microbiology, Virology and infection Prevention &amp; Control, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dembinski</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Virology, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diedrich</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Reference Center for Poliomyelitis and Enteroviruses, Robert Koch Institute, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dudman</LastName><ForeName>S G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Oslo University Hospital Rikshospitalet, Inst. Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dyrdak</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eltringham</LastName><ForeName>G J A</ForeName><Initials>GJA</Initials><AffiliationInfo><Affiliation>Molecular Diagnostics Laboratory, Microbiology, Freeman Hospital, Newcastle Upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzales-Goggia</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Public Health England Poliovirus Reference Laboratory, National Infection Service, Public Health England, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunson</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>West of Scotland Specialist Virology Centre, Glasgow Royal Infirmary, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howson-Wells</LastName><ForeName>H C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Nottingham University Hospitals NHS Trust, Clinical Microbiology, Queens Medical Centre, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>J&#xe4;&#xe4;skel&#xe4;inen</LastName><ForeName>A J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>University of Helsinki and Helsinki University Hospital, HUSLAB, Virology and Immunology, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Labrador</LastName><ForeName>F X</ForeName><Initials>FX</Initials><AffiliationInfo><Affiliation>Virology Laboratory, Joint Units in Genomics and Health and Infection and Health, Fundaci&#xf3;n para el Fomento de la Investigaci&#xf3;n Sanitaria y Biom&#xe9;dica de la Comunidad Valenciana (FISABIO-Public Health)/Universitat de Val&#xe8;ncia, Av. Catalunya, Val&#xe8;ncia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBEResp, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Epidemiolog&#xed;a y Salud P&#xfa;blica, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Virology, Leipzig University Hospital, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majumdar</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The National Institute for Biological Standards and Control, Hertfordshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Midgley</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Virus and Special Microbiological Diagnostics, Virus Surveillance and Research Section, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirand</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CHU Clermont-Ferrand, Laboratoire de Virologie-Centre National de R&#xe9;f&#xe9;rence des Ent&#xe9;rovirus et Parechovirus, Laboratoire Associ&#xe9;-Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morley</LastName><ForeName>U</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>UCD National Virus Reference Laboratory, University College Dublin, Belfield, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nordb&#xf8;</LastName><ForeName>S A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, St. Olavs University Hospital, Trondheim, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oikarinen</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osman</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Public Health England Birmingham Public Health Laboratory, Heartlands Hospital, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papa</LastName><ForeName>A</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6643-3322</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrinelli</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piralla</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rabella</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Virology Section, Santa Creu i Sant Pau University Hospital, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Molecular Virology, Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College Hospital, Bessemer Wing, Denmark Hill, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf6;derlund Strand</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory Medicine, Department of Clinical Microbiology, Lund University Hospital, S&#xf6;lvegatan, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Templeton</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Edinburgh Specialist Virology, Royal Infirmary of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vipond</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Public Health England, South West Regional Laboratory, Pathology Sciences Building, Science Quarter, Southmead Hospital, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuorinen</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Clinical Microbiology, Turku University Hospital and Institute of Biomedicine University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Microbiology, Royal Oldham Hospital, Oldham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wollants</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical and Epidemiological Virology, KU Leuven, REGA Institute, Clinical and Epidemiological Virology, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zakikhany</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Katherina Zakikhany-Gilg, Public Health Agency of Sweden, Department of Microbiology, Unit of Laboratory Surveillance of Viral Pathogens and Vaccine Preventable Diseases, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>T K</ForeName><Initials>TK</Initials><AffiliationInfo><Affiliation>CIBEResp, Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red en Epidemiolog&#xed;a y Salud P&#xfa;blica, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Virus and Special Microbiological Diagnostics, Virus Surveillance and Research Section, Statens Serum Institut, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harvala</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>NHS Blood and Transplant, Colindale, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simmonds</LastName><ForeName>P</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-7964-4700</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>ISSF204826/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011933">Reagent Kits, Diagnostic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018628" MajorTopicYN="N">Gene Dosage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008587" MajorTopicYN="N">Meningitis, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058889" MajorTopicYN="N">Molecular Typing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030061" MajorTopicYN="N">Parechovirus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="N">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011933" MajorTopicYN="N">Reagent Kits, Diagnostic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PCR</Keyword><Keyword MajorTopicYN="N">RNA transcripts</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">enterovirus A71</Keyword><Keyword MajorTopicYN="N">parechovirus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>9</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31883139</ArticleId><ArticleId IdType="pmc">PMC7496258</ArticleId><ArticleId IdType="doi">10.1002/jmv.25659</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stanway G, Brown F, Christian P, et al. Family Picornaviridae In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, eds. Virus Taxonomy. Eighth Report of the International Committee on Taxonomy of Viruses. London: Elsevier/Academic Press; 2005:757&#x2010;778.</Citation></Reference><Reference><Citation>Mulders MN, Salminen M, Kalkkinen N, Hovi T. Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2A(pro) cleavage site: evidence for high genomic diversity and long&#x2010;term endemicity of distinct genotypes. J Gen Virol. 2000;81(Pt 3):803&#x2010;812.</Citation><ArticleIdList><ArticleId IdType="pubmed">10675418</ArticleId></ArticleIdList></Reference><Reference><Citation>Holm&#x2010;Hansen CC, Midgley SE, Fischer TK. Global emergence of enterovirus D68: a systematic review. Lancet Infect Dis. 2016;16(5):e64&#x2010;e75.</Citation><ArticleIdList><ArticleId IdType="pubmed">26929196</ArticleId></ArticleIdList></Reference><Reference><Citation>Boivin G, Abed Y, Boucher FD. Human parechovirus 3 and neonatal infections. EmergInfect Dis. 2005;11(1):103&#x2010;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3294360</ArticleId><ArticleId IdType="pubmed">15705330</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop KSM, Schinkel J, Minnaar RP, et al. Human parechovirus infections in Dutch children and the association between serotype and disease severity. ClinInfect Dis 2006;42(2):204&#x2010;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">16355330</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Robertson I, McWilliam Leitch C, Chieochansin T, Templeton K, Simmonds P. Aetiological role of human parechovirus type 3 in neonatal sepsis identified by direct typing assay on cerebrospinal fluid. J Infect Dis. 2009;199(12):1753&#x2010;1760.</Citation><ArticleIdList><ArticleId IdType="pubmed">19456229</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Broberg E, Benschop K, et al. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J Clin Virol. 2018;101:11&#x2010;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">29414181</ArticleId></ArticleIdList></Reference><Reference><Citation>Nix WA, Oberste MS, Pallansch MA. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol. 2006;44(8):2698&#x2010;2704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1594621</ArticleId><ArticleId IdType="pubmed">16891480</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Robertson I, McWilliam Leitch EC, et al. Epidemiology and clinical associations of human parechovirus respiratory infections. J Clin Microbiol. 2008;46:3446&#x2010;3453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2566073</ArticleId><ArticleId IdType="pubmed">18753351</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeish NJ, Witteveldt J, Clasper L, et al. Development and assay of RNA transcripts of enterovirus species A to D, rhinovirus species a to C, and human parechovirus: assessment of assay sensitivity and specificity of real&#x2010;time screening and typing methods. J Clin Microbiol. 2012;50(9):2910&#x2010;2917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3421820</ArticleId><ArticleId IdType="pubmed">22740708</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Tee HK, Lee MH, Sam IC, Chan YF. Enterovirus A71 DNA&#x2010;launched infectious clone as a robust reverse genetic tool. PLOS One. 2016;11(9):1&#x2010;17. e0162771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5019408</ArticleId><ArticleId IdType="pubmed">27617744</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop KSM, de Vries M, Minnaar RP, et al. Comprehensive full length sequence analyses of human parechoviruses; diversity and recombination. J Gen Virol. 2010;91:151&#x2010;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">19759239</ArticleId></ArticleIdList></Reference><Reference><Citation>Dierssen U, Rehren F, Henke&#x2010;Gendo C, Harste G, Heim A. Rapid routine detection of enterovirus RNA in cerebrospinal fluid by a one&#x2010;step real&#x2010;time RT&#x2010;PCR assay. JClinVirol. 2008;42(1):58&#x2010;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">18164234</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheltinga SA, Templeton KE, Beersma MF, Claas EC. Diagnosis of human metapneumovirus and rhinovirus in patients with respiratory tract infections by an internally controlled multiplex real&#x2010;time RNA PCR. J Clin Virol. 2005;33(4):306&#x2010;311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185544</ArticleId><ArticleId IdType="pubmed">15994117</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop K, Molenkamp R, van der Ham A, Wolthers K, Beld M. Rapid detection of human parechoviruses in clinical samples by real&#x2010;time PCR. JClinVirol. 2008;41(2):69&#x2010;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">18354819</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Jasir A, Penttinen P, Pastore Celentano L, Greco D, Broberg E. Surveillance and laboratory detection for non&#x2010;polio enteroviruses in the European Union/European Economic Area, 2016. Euro Surveill. 2017;22(45):1&#x2010;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5718392</ArticleId><ArticleId IdType="pubmed">29162204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett S, Harvala H, Witteveldt J, et al. Rapid simultaneous detection of enterovirus and parechovirus RNAs in clinical samples by one&#x2010;step real&#x2010;time reverse transcription&#x2010;PCR assay. J Clin Microbiol. 2011;49(7):2620&#x2010;2624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3147812</ArticleId><ArticleId IdType="pubmed">21593263</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccirilli G, Chiereghin A, Gabrielli L, et al. Infectious meningitis/encephalitis: evaluation of a rapid and fully automated multiplex PCR in the microbiological diagnostic workup. New Microbiol. 2018;41(2):118&#x2010;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">29620789</ArticleId></ArticleIdList></Reference><Reference><Citation>Leber AL, Everhart K, Balada&#x2010;Llasat JM, et al. Multicenter evaluation of BioFire filmarray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol. 2016;54(9):2251&#x2010;2261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5005480</ArticleId><ArticleId IdType="pubmed">27335149</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Breazeale G, Robinson CC, Dominguez SR. Potential clinical impact of the film array meningitis encephalitis panel in children with suspected central nervous system infections. Diagn Microbiol Infect Dis. 2016;86(1):118&#x2010;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4993637</ArticleId><ArticleId IdType="pubmed">27342782</ArticleId></ArticleIdList></Reference><Reference><Citation>Liesman RM, Strasburg AP, Heitman AK, Theel ES, Patel R, Binnicker MJ. Evaluation of a commercial multiplex molecular panel for diagnosis of infectious meningitis and encephalitis. J Clin Microbiol. 2018;56(4):1&#x2010;9. e01927&#x2010;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869843</ArticleId><ArticleId IdType="pubmed">29436421</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Griffiths M, Solomon T, Simmonds P. Distinct systemic and central nervous system disease patterns in enterovirus and parechovirus infected children. J Infect. 2014;69(1):69&#x2010;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">24662038</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S, Schibler M, L'Huillier AG, et al. Comparative analysis of viral shedding in pediatric and adult subjects with central nervous system&#x2010;associated enterovirus infections from 2013 to 2015 in Switzerland. J Clin Virol. 2017;89:22&#x2010;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">28214758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafolie J, Labb&#xe9; A, L'Honneur AS, et al. Assessment of blood enterovirus PCR testing in paediatric populations with fever without source, sepsis&#x2010;like disease, or suspected meningitis: a prospective, multicentre, observational cohort study. Lancet Infect Dis. 2018;18(12):1385&#x2010;1396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164799</ArticleId><ArticleId IdType="pubmed">30389482</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>